HRH The Duke of Gloucester officially opens cancer centre in the north-east
The Rutherford Cancer Centre North East has been officially opened by HRH The Duke of Gloucester, heralding a milestone for advanced cancer care in the region.
Built at a cost of £35 million, the centre was established near Bedlington, Northumberland, to meet patient demand in an area that has among the highest incidence of cancer in the UK. It offers chemotherapy, immunotherapy, radiotherapy and high energy proton beam therapy to private paying, insured and NHS patients.
Rutherford Health ceo Mike Moran said: “We are delighted and honoured that HRH The Duke of Gloucester officially opened the centre in what is a momentous day for cancer care in the north-east. This centre will play a fundamental role in turning the tide against cancer in the region and extends patient choice in the range of treatments that are available to them.”
Sir James Mackey is ceo of Northumbria Healthcare NHS Foundation Trust, which sends chemotherapy patients to the centre. He said: “The health and care system in Northumberland is proven to be one of the best in England, something we are all very proud of. Adding now the additional services from the Rutherford Cancer Centre ensures patients continue to get access to the latest and most advanced treatments for cancer.”
Lead picture: HRH The Duke of Gloucester unveils an opening plaque with Rutherford Health ceo Mike Moran.
Published on page 12 of the November 2019 issue of RAD Magazine.
